Improving access to pulmonary rehabilitation for COPD patients
HomeBase2: An Implementation Trial to Improve Access to Pulmonary Rehabilitation in People With Chronic Obstructive Pulmonary Disease
This study tests whether giving people with COPD the choice between home-based and center-based rehabilitation programs can help them complete their treatment and improve their health.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 490 (estimated) |
| Sex | All |
| Sponsor | Monash University Academic / other |
| Locations | 11 sites (Sydney, New South Wales and 10 other locations) |
| Trial ID | NCT04217330 on ClinicalTrials.gov |
What this trial studies
This trial investigates a new approach to pulmonary rehabilitation for individuals with chronic obstructive pulmonary disease (COPD) by offering them a choice between home-based and center-based rehabilitation programs. The HomeBase model, previously shown to have equivalent outcomes to traditional center-based rehabilitation, aims to enhance program completion rates and reduce hospitalizations. By implementing this patient-centered model, the study seeks to determine if providing options can lead to better health outcomes and more efficient use of healthcare resources.
Who should consider this trial
Good fit: Ideal candidates for this study are adults diagnosed with COPD who can read, write, and speak English and are willing to provide informed consent.
Not a fit: Patients who have attended pulmonary rehabilitation within the past year or have comorbidities that prevent them from participating in exercise training may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve access to pulmonary rehabilitation for COPD patients, leading to better management of their condition and reduced hospital visits.
How similar studies have performed: Other studies have shown success with similar patient-centered approaches to pulmonary rehabilitation, indicating potential for positive outcomes in this trial.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion criteria for pulmonary rehabilitation programs: • Outpatient pulmonary rehabilitation programs that admit at least 50 people with COPD each year. Inclusion criteria for participants: * Diagnosis of COPD confirmed on spirometry * Able to read, write and speak English * Able to provide informed consent. Exclusion Criteria: * Attended pulmonary rehabilitation within 1 year * Comorbidities which preclude exercise training.
Where this trial is running
Sydney, New South Wales and 10 other locations
- Royal Prince Alfred Hospital — Sydney, New South Wales, Australia (Recruiting)
- Mount Druitt Hospital — Sydney, New South Wales, Australia (Not_yet_recruiting)
- Prince of Wales Hospital — Sydney, New South Wales, Australia (Recruiting)
- Westmead Hospital — Sydney, New South Wales, Australia (Not_yet_recruiting)
- Top End Health Service — Darwin, Northern Territory, Australia (Not_yet_recruiting)
- Prince Charles Hospital — Brisbane, Queensland, Australia (Not_yet_recruiting)
- Central Adelaide Local Health Network — Adelaide, South Australia, Australia (Not_yet_recruiting)
- Southern Adelaide Local Health Network — Adelaide, South Australia, Australia (Recruiting)
- Peninsula Health — Melbourne, Victoria, Australia (Not_yet_recruiting)
- St John of God Frankston Rehabilitation — Melbourne, Victoria, Australia (Not_yet_recruiting)
- Western Health — Melbourne, Victoria, Australia (Not_yet_recruiting)
Study contacts
- Principal investigator: Anne Holland — Monash University
- Study coordinator: Anne Holland
- Email: a.holland@alfred.org.au
- Phone: +61 3 99030214
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.